Add-on Acquisition • Life Science

Generic Specialties Acquires Axcellerate Pharma

On May 17, 2016, Generic Specialties acquired life science company Axcellerate Pharma

Acquisition Context

This is Generic Specialties’ 1st transaction in the Life Science sector.
This is Generic Specialties’ 1st transaction in the United States.
This is Generic Specialties’ 1st transaction in New Jersey.

Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	May 17, 2016
Target	Axcellerate Pharma
Sector	Life Science
Buyer(s)	Generic Specialties
Deal Type	Add-on Acquisition

Target Company

Axcellerate Pharma

Piscataway, New Jersey, United States

Axcellerate Pharma LLC is a contract research organization and contract development and manufacturing organization (CRO/CDMO) focused on the development and manufacturing of sterile injectable products for generics and biologics.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Generic Specialties

Orlando, Florida, United States

Category	Company
Founded	1999
Sector	Life Science

DESCRIPTION

Generic Specialties, Inc. is a generic pharmaceutical company engaged in the manufacture, acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the U.S. prescription drug market.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: New Jersey	1 of 1
Country: United States	1 of 1
Year: 2016	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - New Jersey M&A - United States M&A - 2016 M&A